Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice

Added 99 days ago (25.08.2021)
Authors: Stefano Tarantini; Priya Balasubramanian; Jordan Delfavero; Tamas Csipo; Andriy Yabluchanskiy; Tamas Kiss; Ádám Nyúl-Tóth; Peter Mukli; Peter Toth; Chetan Ahire; Anna Ungvari; Zoltan Benyo; Anna Csiszar; Zoltan Ungvari
Journal: GeroScience
Read article